Quantifying Barriers to Diabetic Eye Screening: A Two-Center Study at the University of California
Many patients with T2DM remain unscreened after primary care visits. Although an automated referral system may partially improve adherence, additional tailored strategies are needed.
Authors
- Mitul C. Mehta (ORCID: https://orcid.org/0000-0002-5467-6220)
- Aryan Ayati (ORCID: https://orcid.org/0000-0002-0241-6865)
- David Tabano (ORCID: https://orcid.org/0000-0001-7657-0809)
- Michelle Wang (ORCID: https://orcid.org/0000-0002-3207-1490)
- Vivek A. Rudrapatna (ORCID: https://orcid.org/0000-0003-1789-3004)
- Frank Brodie (ORCID: https://orcid.org/0000-0002-6908-6557)
- Claude Bendavid (ORCID: https://orcid.org/0000-0003-2459-9567)
- Nina Malik
- Nicole Bonine
- Stella Ko
- Shadera Azzam
Institutions
- University of California, San Francisco (US)
- University of California, Irvine (US)
- Kaiser Permanente South San Francisco Medical Center (US)
Publication Details
- Journal
- Diabetes Care
- Published
- 2025-09-09
- DOI
- https://doi.org/10.2337/dc25-0951
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- American Diabetes Association
- Research to Prevent Blindness
- Stryker
- Ironwood Pharmaceuticals, Incorporated
- Apellis Pharmaceuticals
- Natera
- Astellas Pharma
- Genentech
- University of California, San Francisco